Welcome to the Fact Sheet Exchange Portal for MDL 2592 In Re Xarelto (Rivaroxaban) Products Liability Litigation
MDL CENTRALITY ACCESS WARNING
It appears that there is an open session attached to this login ID. That other login session may have occurred because you have logged into the system from a different computer or you may have closed your browser without first logging out of MDL CENTRALITY portal. If you want this new attempt to become your primary session and close the other session(s) select CONTINUE and it will close previous session immediately. If you want the previous session to remain open, please select CANCEL and this current session will be closed.
Welcome to MDL Centrality. In its Pre-Trial Order regarding Plaintiff and Defendant Fact Sheets, the United States District Court for the Eastern District of Louisiana ordered all parties to use MDL Centrality to exchange Plaintiff and Defendant Fact Sheets electronically.
If you already have access to MDL Centrality for another case, you may use the same login ID and password to log in below. If you need access to MDL Centrality, click
here
to register on the main website. If you need assistance, please contact us at
MDLCentrality@browngreer.com
.
Login ID:
*
Login ID must meet the following requirements:
- At least 6 characters long.
- No spaces.
Password:
*
Password must meet the following requirements:
- At least one capital letter.
- At least one special character.
- At least one number.
- At least 8 characters long and max 15 characters only.
- No spaces.
If you have a Xarelto-related claim and do not have a lawyer, email us at
mdlcentrality@browngreer.com
to request access to the Xarelto portal. If you prefer to submit a paper copy of the Pro Se Registration form, click
here
to download the form.
Unauthorized use of this system is prohibited. Use is restricted to authorized users. Violators may be subject to disciplinary actions including civil and criminal prosecution and loss of employment. All transactions are monitored.